Does zinc deficiency impair antioxidant defense, immune surveillance, tissue repair, and mitochondrial protection?

Clinical and physiological evidence

Zinc is a critical structural and functional trace element, and its deficiency systematically undermines systemic homeostasis across several physiological domains:

• Antioxidant defense: Zinc deficiency destabilizes cytosolic copper-zinc superoxide dismutase (Cu/Zn-SOD), significantly reducing its enzymatic capacity. It downregulates the Nrf2 signaling pathway, which suppresses downstream antioxidant genes (such as HO-1, NQO1, and glutathione-dependent enzymes) and blunts metallothionein induction.
• Immune surveillance: Zinc deficiency causes structural and functional thymic involution (atrophy), primarily of the thymic cortex. This impairs the activation of thymulin, a zinc-dependent hormone essential for T-cell maturation. Consequently, T-cell selection is disrupted, leading to depressed adaptive immunity, altered CD4+/CD8+ ratios, decreased Th1 cytokines (IFN-$\gamma$, IL-2), and impaired natural killer (NK) cell lytic activity.
• Tissue repair: Healing is impaired as zinc depletion suppresses keratinocyte proliferation, survival, and migration, delaying wound re-epithelialization. It also dysregulates matrix metalloproteinases (MMPs), leading to abnormal extracellular matrix remodeling and a reduced collagen type I/III ratio.
• Mitochondrial protection: Depleting zinc removes a critical inhibitory brake on mitochondrial outer membrane permeabilization, triggering the opening of the mitochondrial permeability transition pore (mPTP) and the activation of pro-apoptotic Bax and Bak. This depolarizes the mitochondrial membrane, initiates a cascade of mitochondrial reactive oxygen species (ROS) generation, and promotes cytochrome c release.

Mechanistic explanations

• Fenton reaction acceleration: Under normal conditions, redox-inactive zinc competes with redox-active transition metals (such as iron and copper) for binding sites on phospholipid membranes. In zinc's absence, unbound iron and copper catalyze Fenton-type reactions, driving lipid peroxidation (evidenced by elevated malondialdehyde levels).
• Inactive Apo-thymulin: Although the thymus synthesizes thymulin peptide during zinc deficiency, the hormone is secreted in its inactive, zinc-free apo-form. This halts thymopoiesis and reduces the generation of functional cytolytic and helper T cells.
• ZIP8/MnSOD axis: Mitochondrial zinc transporters like ZIP8 are essential for organellar homeostasis. Dysregulation of ZIP-mediated import pathways limits manganese delivery to manganese superoxide dismutase (MnSOD/SOD2), which compromises mitochondrial redox defense, leading to bioenergetic failure and reduced oxygen consumption.

Clinical implications

• Targeted repletion benefits: Clinical trials indicate that corrective zinc supplementation is highly effective in restoring immune surveillance, normalizing serum thymulin activity, and stimulating thymopoiesis.
• Wound healing efficacy: Zinc repletion significantly accelerates tissue repair in patients with baseline zinc deficiencies, pressure injuries, or chronic ulcers. However, routine oral supplementation offers no clear clinical benefit for individuals with normal baseline zinc levels.

Bottom line

Zinc deficiency directly impairs antioxidant defense, immune surveillance, tissue repair, and mitochondrial protection through well-defined molecular pathways—including Cu/Zn-SOD destabilization, thymic atrophy via inactive apo-thymulin, MMP dysregulation, and mPTP-mediated mitochondrial depolarization. Corrective supplementation is highly effective at reversing these deficits in individuals with baseline zinc deficiency.